ASX Announcement

36-Month Results of Phase 3 Trial in Chronic Low Back Pain

Published: 12/01/22, 10:05am (AEST)2 pages
Mesoblast Limited
MSB:ASXHealthcare

Recent MSB Announcements

Price Sensitive only